Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK47388 in Moderately to Severely Active Ulcerative Colitis
NCT07335055Phase 2Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Feb 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK47388 in ulcerative colitis (UC), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Feb 2026; status: recruiting.
02
Drugs
HSK47388
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07335055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07335055.